Chaitali Dutta, Ph.D.
Principal Scientist, Pharmacology and Toxicology
Chaitali Dutta is a principal scientist at Verve Therapeutics. She brings over a decade of research experience in both industry and academia, with a focus on in vivo pharmacology and translational biology. Her research has focused on lymphoma, liver diseases and milk exosome drug delivery. Prior to joining Verve, Dr. Dutta held research positions at PureTech Health, Dicerna Pharmaceuticals and AstraZeneca. She holds a Ph.D. in biomedical sciences from University of Massachusetts Medical School and completed a postdoctoral fellowship at Dana-Farber Cancer Institute.